Safety and effectiveness of aflibercept in combination with FOLFIRI in Korean patients with metastatic colorectal cancer who received oxaliplatin-containing regimen

被引：0

作者：

Seung-Hoon Beom

Jong Gwang Kim

Seung Hyuk Baik

Seong Hoon Shin

Inkeun Park

Young Suk Park

Myung-Ah Lee

Soohyeon Lee

So-Yeon Jeon

Sae-Won Han

Myoung Hee Kang

Jisu Oh

Jin Soo Kim

Jin Young Kim

Mi Sun Ahn

Dae Young Zang

Byung-Noe Bae

Hong Jae Jo

Hee Kyung Kim

Jung-Han Kim

Ji Ae Yoon

Dong Han Kim

机构：

[1] Yonsei University College of Medicine,Division of Medical Oncology, Department of Internal Medicine

[2] Kyungpook National University Chilgok Hospital,Department of Oncology/Hematology

[3] School of Medicine,Section of Colon and Rectal Surgery, Department of Surgery

[4] Kyungpook National University,Department of Internal Medicine

[5] Yonsei University College of Medicine,Division of Hematology

[6] Gangnam Severance Hospital,Oncology, Department of Internal Medicine

[7] Kosin University Gospel Hospital,Division of Hematology/Oncology, Department of Medicine

[8] Gachon University Gil Medical Center,Division of Medical Oncology, Department of Internal Medicine

[9] Samsung Medical Center,Division of Oncology/Hematology, Department of Internal Medicine

[10] Sungkyunkwan University School of Medicine,Department of Internal Medicine

[11] Cancer Research Institute,Department of Internal Medicine

[12] Seoul St. Mary’s Hospital,Division of Hematology

[13] College of Medicine,Oncology, Department of Internal Medicine

[14] The Catholic University of Korea,Division of Medical Oncology, Department of Internal Medicine

[15] Korea University Anam Hospital,Department of Surgery

[16] Jeonbuk National University Medical School,Division of Hematology and Oncology, Department of Internal Medicine

[17] Seoul National University Hospital and Seoul National University Cancer Research Institute,Department of Hematology

[18] Gyeongsang National University Changwon Hospital,Oncology

[19] Gyeongsang National University College of Medicine,Department of Internal Medicine

[20] Yongin Severance Hospital,Department of Surgery

[21] Chungnam National University College of Medicine,Department of Surgery

[22] Chungnam National University Sejong Hospital,Division of Oncology, Department of Internal Medicine

[23] Keimyung University Dongsan Hospital,Department of Internal Medicine

[24] Ajou University School of Medicine,undefined

[25] Hallym University Medical Center,undefined

[26] Hallym University College of Medicine,undefined

[27] Inje University Sanggye Paik Hospital,undefined

[28] Inje University College of Medicine,undefined

[29] Pusan National University School of Medicine,undefined

[30] Pusan National University Hospital,undefined

[31] Chungbuk National University Hospital,undefined

[32] Chungbuk National University College of Medicine,undefined

[33] Kangnam Sacred-Heart Hospital,undefined

[34] Hallym University College of Medicine,undefined

[35] Medical Affairs of Oncology,undefined

[36] GSK Korea,undefined

来源：

Journal of Cancer Research and Clinical Oncology | 2023年 / 149卷

关键词：

Acquired resistance; Anti-VEGF agents; Chemotherapy; Colorectal cancer;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1131 / 1143

页数：12

共 50 条

[1] Safety and effectiveness of aflibercept in combination with FOLFIRI in Korean patients with metastatic colorectal cancer who received oxaliplatin-containing regimen
Beom, Seung-Hoon
Kim, Jong Gwang
Baik, Seung Hyuk
Shin, Seong Hoon
Park, Inkeun
Park, Young Suk
Lee, Myung-Ah
Lee, Soohyeon
Jeon, So-Yeon
Han, Sae-Won
Kang, Myoung Hee
Oh, Jisu
Kim, Jin Soo
Kim, Jin Young
Ahn, Mi Sun
Zang, Dae Young
Bae, Byung-Noe
Jo, Hong Jae
Kim, Hee Kyung
Kim, Jung-Han
Yoon, Ji Ae
Kim, Dong Han
[J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (03) : 1131 - 1143
[2] Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy
Ruff, Paul
Ferry, David R.
Lakomy, Radek
Prausova, Jana
Van Hazel, Guy A.
Hoff, Paulo M.
Cunningham, David
Arnold, Dirk
Schmoll, Hans J.
Moiseyenko, Vladimir M.
McKendrick, Joseph J.
ten Tije, Albert J.
Vishwanath, Raghu L.
Bhargava, Pankaj
Chevalier, Soazig
Macarulla, Teresa
Van Cutsem, Eric
[J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 (01) : 18 - 26
[3] Efficacy and safety of FOLFIRI/Aflibercept (FA) in an elderly population with metastatic colorectal cancer (mCRC) after the failure of an oxaliplatin-based regimen
Martinez-Lago, N.
Carmona Campos, M.
Gonzalez Villarroel, P.
Salgado Fernandez, M.
De la Camara Gomez, J.
Romero Reinoso, C.
Cousillas Castineiras, A.
Mendez Mendez, J.
Vidal Insua, Y.
Reboredo Rendo, C.
Covela Rua, M.
Quintero Aldana, G.
Grana Suarez, B.
Carral Maseda, A.
Jorge Fernandez, M.
Pellon Augusto, M.
Grande Ventura, C.
Gallardo Martin, E.
Fernandez Montes, A.
Reboredo-Lopez, M.
[J]. ANNALS OF ONCOLOGY, 2019, 30
[4] Efficacy and safety of FOLFIRI/aflibercept (FA) in an elderly population with metastatic colorectal cancer (mCRC) after failure of an oxaliplatin-based regimen
Martinez-Lago, Nieves
Cameselle Garcia, Soledad
Alonso de Castro, Beatriz
Gomez-Randulfe Rodriguez, Martin, I
Carmona Campos, Marta
Gonzalez Villarroel, Paula
Salgado Fernandez, Mercedes
Camara Gomez, Juan C. De la
Romero Reinoso, Carlos
Cousillas Castineiras, Antia
Mendez Mendez, Jose Carlos
Vidal Insua, Yolanda
Fernandez-Montes, Ana
[J]. PLOS ONE, 2022, 17 (06):
[5] Safety and effectiveness of aflibercept plus FOLFIRI for the treatment of patients with metastatic colorectal cancer (mCRC): OZONE secondary analyses
Chau, I.
Fakih, M. G.
Garcia-Alfonso, P.
Linke, Z.
Ruiz-Casado, A.
Polo Marques, E.
Picard, P.
Celanovic, M.
Cartwright, T.
[J]. ANNALS OF ONCOLOGY, 2019, 30 : 227 - 227
[6] Update of metastatic colorectal cancer metastases resection after FOLFIRI-aflibercept in oxaliplatin-refractory patients
de Toro Carmena, M.
Ortega Moran, I.
Garcia Adrian, S.
Castanon Lopez, C.
Molina Villaverde, R.
Marrupe Gonzalez, D.
Lopez Munoz, A.
Alcaraz Nunes, D.
Diaz Beveridge, R.
Lopez Alfonso, A.
Garcia Paredes, B.
Fernandez Montes, A.
Soriano Rodriguez, M.
Encinas Garcia, S.
Alcaide Garcia, I.
Pericay Pijaume, C.
Macarulla Mercade, C.
Redriguez-Salas, N.
Garcia Alfonso, P.
Munoz Martin, A.
[J]. ANNALS OF ONCOLOGY, 2019, 30
[7] Prospective, Observational Study of Aflibercept Use in Combination with FOLFIRI in Patients with Metastatic Colorectal Cancer: A Real-World Effectiveness Study
Durbajlo, Agnieszka
Swiezynski, Marcin
Ziemba, Beata
Starzyczny-Slota, Danuta
Samborska-Plewicka, Marzena
Cencelewicz-Lesikow, Anna
Chrzanowska-Kapica, Agata
Dobrzynska-Rutkowska, Aneta
Drab-Mazur, Iwona
Kulma-Kreft, Monika
Sikora-Skrabaka, Magdalena
Matuszewska, Elwira
Foszczynska-Kloda, Malgorzata
Lewandowski, Tomasz
Slomian, Grzegorz
Ostrowska-Cichocka, Krystyna
Chmielowska, Ewa
Wisniowski, Rafal
Twardosz, Anna
Wierzbicka, Katarzyna
Rumianowski, Leszek
Wyrwicz, Lucjan
[J]. CANCERS, 2024, 16 (11)
[8] Safety and Efficacy of Radiofrequency Ablation with Aflibercept and FOLFIRI in a Patient with Metastatic Colorectal Cancer
Agarwal, Archana
Daly, Kevin Pelham
Butler-Bowen, Harriet
Saif, Muhammad Wasif
[J]. ANTICANCER RESEARCH, 2014, 34 (11) : 6775 - 6778
[9] Quality of life, effectiveness, and safety of aflibercept plus FOLFIRI in older patients with metastatic colorectal cancer: An analysis of the prospective QoLiTrap study
Piringer, Gudrun
Thaler, Josef
Anchisi, Sandro
Geffriaud-Ricouard, Christine
Gueldner, Max
Scholten, Felicitas
Derigs, Hans-Guenter
Bohanes, Pierre
Gruenberger, Birgit
Schwarz, Leonora
von Moos, Roger
Hofheinz, Ralf-Dieter
[J]. JOURNAL OF GERIATRIC ONCOLOGY, 2023, 14 (08)
[10] REOX: Evaluation of the Efficacy of Retreatment With an Oxaliplatin-containing Regimen in Metastatic Colorectal Cancer: A Retrospective Single-center Study
Costa, Talita
Nunez, Jose
Felismino, Tiago
Boente, Leonardo
Mello, Celso
[J]. CLINICAL COLORECTAL CANCER, 2017, 16 (04) : 316 - 323

← 1 2 3 4 5 →